Permanently Discontinued

CIPROFLOXACIN INJECTION

BAXTER CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CIPROFLOXACIN INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CIPROFLOXACIN INJECTION 2MG has been permanently discontinued (last updated August 17, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CIPROFLOXACIN INJECTION not available?

The reason the manufacturer reported: Raw material availability.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength2MG

Last updated2020-08-17

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CIPRO IV 10MG/ML

MILES CANADA INC. - PHARMACEUTICAL DIVISION

10MG · DIN 01947710

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CIPRO I.V. - LIQ 10MG/ML

BAYER INC

10MG · DIN 02155982

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CIPRO TAB 500MG

MILES CANADA INC. - PHARMACEUTICAL DIVISION

500MG · DIN 00817171

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CIPRO TAB 100MG

MILES CANADA INC. - PHARMACEUTICAL DIVISION

100MG · DIN 02100533

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CIPRO TAB 250MG

MILES CANADA INC. - PHARMACEUTICAL DIVISION

250MG · DIN 00817163

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CIPRO TAB 750MG

MILES CANADA INC. - PHARMACEUTICAL DIVISION

750MG · DIN 00817198

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02301296

Strength

2MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

CIPROFLOXACIN

See all CIPROFLOXACIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2020-08-17

Permanently Discontinued

Raw material availability

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217